These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12587520

  • 1. Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine.
    Shimodozono M, Kawahira K, Kamishita T, Ogata A, Tohgo S, Tanaka N.
    Int J Neurosci; 2002 Oct; 112(10):1173-81. PubMed ID: 12587520
    [Abstract] [Full Text] [Related]

  • 2. [Additional treatment in chronic pain syndrome due to hip and knee arthritis with the selective serotonin reuptake inhibitor fluvoxamine (Fevarin].
    Riesner HJ, Zeitler C, Schreiber H, Wild A.
    Z Orthop Unfall; 2008 Oct; 146(6):742-6. PubMed ID: 19085723
    [Abstract] [Full Text] [Related]

  • 3. Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study.
    Silver H, Shmugliakov N.
    J Clin Psychopharmacol; 1998 Jun; 18(3):208-11. PubMed ID: 9617979
    [Abstract] [Full Text] [Related]

  • 4. [Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder].
    Fukuda T, Sugie H, Ito M, Sugie Y.
    No To Hattatsu; 2001 Jul; 33(4):314-8. PubMed ID: 11494573
    [Abstract] [Full Text] [Related]

  • 5. Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine.
    Manna V, Bolino F, Di Cicco L.
    Headache; 1994 Jan; 34(1):44-9. PubMed ID: 8132440
    [Abstract] [Full Text] [Related]

  • 6. [Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder].
    Sugie Y, Sugie H, Fukuda T, Ito M, Ohzeki T.
    No To Hattatsu; 2003 Jan; 35(1):23-8. PubMed ID: 12607287
    [Abstract] [Full Text] [Related]

  • 7. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
    Asnis GM, Hameedi FA, Goddard AW, Potkin SG, Black D, Jameel M, Desagani K, Woods SW.
    Psychiatry Res; 2001 Aug 05; 103(1):1-14. PubMed ID: 11472786
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Ushiroyama T, Ikeda A, Ueki M.
    J Med; 2004 Aug 05; 35(1-6):151-62. PubMed ID: 18084873
    [Abstract] [Full Text] [Related]

  • 9. Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial.
    Farahani RH, Ajam A, Naeini AR.
    BMC Infect Dis; 2023 Mar 31; 23(1):197. PubMed ID: 37003990
    [Abstract] [Full Text] [Related]

  • 10. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
    den Boer JA, Westenberg HG, De Leeuw AS, van Vliet IM.
    Int Clin Psychopharmacol; 1995 Jan 31; 9 Suppl 4():47-52. PubMed ID: 7622824
    [Abstract] [Full Text] [Related]

  • 11. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B.
    J Clin Psychopharmacol; 1998 Aug 31; 18(4):274-81. PubMed ID: 9690692
    [Abstract] [Full Text] [Related]

  • 12. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.
    Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E.
    J Clin Psychiatry; 2000 Jan 31; 61(1):26-9. PubMed ID: 10695642
    [Abstract] [Full Text] [Related]

  • 13. Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study.
    Zheng H, Jia F, Han H, Wang S, Guo G, Quan D, Li G, Huang H.
    Eur Neuropsychopharmacol; 2019 Mar 31; 29(3):397-404. PubMed ID: 30595354
    [Abstract] [Full Text] [Related]

  • 14. A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
    Sunami E, Usuda K, Nishiyama Y, Otori T, Katsura K, Katayama Y.
    Intern Med; 2012 Mar 31; 51(10):1187-93. PubMed ID: 22687788
    [Abstract] [Full Text] [Related]

  • 15. A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder.
    Turkington D, Grant JB, Ferrier IN, Rao NS, Linsley KR, Young AH.
    J Clin Psychiatry; 2002 Sep 31; 63(9):778-81. PubMed ID: 12363117
    [Abstract] [Full Text] [Related]

  • 16. Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial.
    Hirsh-Rokach B, Spectre G, Shai E, Lotan A, Ritter A, Al-Aieshy F, Malmström RE, Varon D, Alcalai R.
    Pharmacotherapy; 2015 Feb 31; 35(2):140-7. PubMed ID: 25689244
    [Abstract] [Full Text] [Related]

  • 17. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
    Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B.
    Am J Psychiatry; 1999 May 31; 156(5):756-60. PubMed ID: 10327910
    [Abstract] [Full Text] [Related]

  • 18. Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors.
    Honda M, Uchida K, Tanabe M, Ono H.
    Neuropharmacology; 2006 Sep 31; 51(4):866-72. PubMed ID: 16846619
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.